Advertisement.

GH Projected Dividend Yield

Guardant Health Inc ( NASDAQ : GH )

Guardant Health is a precision oncology company focused on helping conquer cancer through use of its proprietary tests, data sets and analytics. Co.'s Guardant Health Oncology Platform is designed to utilize its capabilities in technology, clinical development, regulatory and reimbursement. Co. engages in the clinical liquid biopsy market with its tests. Co.'s Guardant360 test is a molecular diagnostic test measuring cancer-related genes, and its GuardantOMNI test has a 500-gene panel, both of which analyze circulating tumor DNA in blood. Co. has launched its Guardant Reveal liquid biopsy-based tests for residual and recurring cancer to address the need in Stage II-III colorectal cancer.

20 YEAR PERFORMANCE RESULTS

GH Dividend History Detail
GH Dividend News
GH Competitors News

# of Shares: 0

Closing Price: 34.76

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000